New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:00 EDTRADRite Aid benefiting from generic rebid and Cymbalta launch, says Cleveland
Cleveland Research said Rite Aid's gross profits are benefiting from a recent RFP for its generic business which will likely result in savings of 3% and the Cymbalta generic launch that is running above expectations, which should offset reimbursement pressures.
News For RAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
06:53 EDTRADRite Aid shareholders vote to change CEO payment terms, Reuters says
Subscribe for More Information
June 24, 2015
10:24 EDTRADRite Aid completes acquisition of EnvisionRx in deal valued at approx. $2B
Subscribe for More Information
10:19 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
June 23, 2015
10:30 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
June 22, 2015
10:21 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
June 19, 2015
13:38 EDTRADOptions with decreasing implied volatility
Options with decreasing implied volatility: QIHU PIR RHT BLUE KMX RAD KBH ADBE ACM KR
10:48 EDTRADStocks with call strike movement; RIG RAD
Subscribe for More Information
June 18, 2015
12:04 EDTRADActive options: AAPL ORCL FB RAD BAC HTZ MU GE TSLA AMZN BABA KO
Subscribe for More Information
09:44 EDTRADRite Aid falls, levels to watch
Subscribe for More Information
09:35 EDTRADActive equity options trading on open
Subscribe for More Information
09:04 EDTRADOn The Fly: Pre-market Movers
Subscribe for More Information
07:04 EDTRADRite Aid cuts FY16 EPS view to 14c-22c from 19c-27c
Subscribe for More Information
07:01 EDTRADRite Aid reports Q1 EPS 2c including items, consensus 3c
EPS includes 2c on an after-tax basis, incurred in connection with the company’s pending acquisition of EnvisionRx. These incremental costs were partially offset by an increase in Adjusted EBITDA. Reports Q1 revenue $6.6B, consensus $6.65B. Reports Q1 SSS up 2.9%, consisting of a 0.6% increase in front-end sales and a 3.9% increase in pharmacy sales.
June 17, 2015
15:16 EDTRADNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Rite Aid (RAD), consensus 3c... Kroger (KR), consensus $1.22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use